From development through clinical phase I-III to full commercial production of vaccines in vials and pre-filled syringes
IDT Biologika specializes in the contract development and manufacturing of
vaccines, gene therapy medicinal products, sterile liquids and lyophilized biologics.
We provide GMP compliant end-to-end services in BSL2 facilites meeting FDA
standards. Our process development and cGMP clinical manufacturing capabilities
and our experience with multiple technology platforms provide a comprehensive
foundation for developing processes for live and attenuated vaccine candidates
emerging from the research lab for advancing through clinical development to
IDT Biologika offers vaccine manufacturing from bulk drug substance to sterile filling
through quality control and efficient packaging. The competencies and capabilities
reach from early development delivering test samples in small volumes to largescale industrial vaccine production.
Many human vaccines developed by IDT Biologika, together with international
partners, are already in use, fighting infectious diseases like tuberculosis, AIDS,
malaria,cancer, dengue and Ebola.